Last 12 months
Inside the activity.
25 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 13 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 8 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 14, 2025 Filed Nov 18, 2025 01:08 UTC |
Decker Mark Okey JrDirector · CEO and President
|
PurchaseCommon Stock | 4,093 | $32.41 | $132,654.13 |
DisclosureSEC source: 0001104659-25-113327 · tm2531517-1_4seq1.xml · nonDerivative · entry 1 Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,867 F1 · balance_after: Shares are reflected on a post-split basis in accordance with the 1-for-5 reverse stock split of the Issuer's issued and outstanding shares of common stock completed on September 19, 2025, including the Reporting Person's receipt of cash in lieu of a fractional share. Read SEC document |
| August 26, 2025 Filed Aug 26, 2025 21:13 UTC |
Cypher MatthewDirector
|
PurchaseCommon Stock | 1,350 | $7.38 | $9,960.44 |
DisclosureSEC source: 0001104659-25-083143 · tm2524427-1_4seq1.xml · nonDerivative · entry 1 Cypher Matthew · CIK 0001670718 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,350 Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 20:15 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
SaleCommon Stock | 130,000 | $6.62 | $861,068.00 |
DisclosureSEC source: 0001104659-25-079799 · tm2523767-2_4seq1.xml · nonDerivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: This is the weighted average price. Shares were sold in multiple transactions at prices ranging from $6.50 to $6.74. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The amount reflected has been rounded to four decimal points. Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 20:15 UTC |
Decker Mark Okey JrDirector · CEO and President
|
PurchaseCommon Stock | 17,023 | $6.87 | $116,948.01 |
DisclosureSEC source: 0001104659-25-079792 · tm2523767-1_4seq1.xml · nonDerivative · entry 2 Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 190,894 Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 20:15 UTC |
Decker Mark Okey JrDirector · CEO and President
|
PurchaseCommon Stock | 13,871 | $6.84 | $94,877.64 |
DisclosureSEC source: 0001104659-25-079792 · tm2523767-1_4seq1.xml · nonDerivative · entry 1 Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,871 Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:01 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
Exercise / conversionOP Unit · Derivative | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-075670 · tm2522975-1_4seq1.xml · derivative · entry 4 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 130,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date. F1 · kind: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement. F1 · price: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement. F4 · price: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date. F4 · derivative.exercise_date: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date. F4 · derivative.expiration_date: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:01 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
Exercise / conversionOP Unit · Derivative | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-075670 · tm2522975-1_4seq1.xml · derivative · entry 3 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date. F1 · kind: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement. F1 · price: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement. F4 · price: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date. F4 · derivative.exercise_date: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date. F4 · derivative.expiration_date: Represents OP Units in the OP. Each OP Unit may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. OP Units have no expiration date. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:01 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
Exercise / conversionLTIP Unit · Derivative | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-075670 · tm2522975-1_4seq1.xml · derivative · entry 2 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,573 Underlying: Common Stock · 130,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Represents LTIP Units in the OP. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F3 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for an equivalent number of OP Units. OP Units may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. LTIP Units have no expiration date. F1 · kind: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement. F1 · price: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement. F3 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for an equivalent number of OP Units. OP Units may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: Represents LTIP Units in the OP. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F3 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for an equivalent number of OP Units. OP Units may be redeemed for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:01 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 130,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-075670 · tm2522975-1_4seq1.xml · nonDerivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement. F1 · price: 130,000 of the reporting person's long-term incentive plan units ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of Global Medical REIT Inc. (the "Issuer"), were converted into common units of limited partnership interest ("OP Units") in the OP by the reporting person and the OP Units were redeemed for an equal number of shares of the Issuer's Common Stock in accordance with the OP's partnership agreement. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 00:24 UTC |
Decker Mark Okey JrDirector · CEO and President
|
PurchaseCommon Stock | 18,503 | $6.54 | $120,991.12 |
DisclosureSEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · nonDerivative · entry 5 Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,000 F5 · price: This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.4925 to $6.615, inclusive. The amount reflected has been rounded to four decimal points. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 00:24 UTC |
Decker Mark Okey JrDirector · CEO and President
|
PurchaseCommon Stock | 8,072 | $6.56 | $52,980.57 |
DisclosureSEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · nonDerivative · entry 4 Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,497 F4 · price: This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.555 to $6.585, inclusive. The amount reflected has been rounded to four decimal points. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 00:24 UTC |
Decker Mark Okey JrDirector · CEO and President
|
PurchaseCommon Stock | 30,757 | $6.47 | $198,862.46 |
DisclosureSEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · nonDerivative · entry 3 Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,425 F3 · price: This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.44 to $6.505, inclusive. The amount reflected has been rounded to four decimal points. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 00:24 UTC |
Decker Mark Okey JrDirector · CEO and President
|
PurchaseCommon Stock | 2,668 | $6.37 | $16,993.83 |
DisclosureSEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · nonDerivative · entry 2 Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,668 F2 · price: This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.32 to $6.40, inclusive. The amount reflected has been rounded to four decimal points. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 00:24 UTC |
Decker Mark Okey JrDirector · CEO and President
|
PurchaseCommon Stock | 100,000 | $6.53 | $652,700.00 |
DisclosureSEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · nonDerivative · entry 1 Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · price: This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.31 to $6.60, inclusive. The amount reflected has been rounded to four decimal points. The reporting person undertakes to provide to Global Medical REIT Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) through (5) to this Form 4. Read SEC document |
| June 23, 2025 Filed Jun 26, 2025 00:24 UTC |
Decker Mark Okey JrDirector · CEO and President
|
GrantLTIP Unit (Right to Buy) · Derivative | 158,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-062678 · tm2518804-2_4seq1.xml · derivative · entry 6 Decker Mark Okey Jr · CIK 0001681625 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,730 Underlying: Common Stock · 158,730 shares Expires not disclosed F6 · security: Represents units of limited partnership interests ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer, that were granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan (as amended from time to time) in connection with the Reporting Person's appointment as President and Chief Executive Officer, effective June 23, 2025 (the "grant date"). All of the LTIP Units vest on the third anniversary of the grant date. F7 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F7 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F7 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 14, 2025 Filed May 15, 2025 12:16 UTC |
Cypher MatthewDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 11,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-049024 · tm2515150-4_4seq1.xml · derivative · entry 1 Cypher Matthew · CIK 0001670718 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,526 Underlying: Common Stock · 11,518 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 14, 2026, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 14, 2025 Filed May 15, 2025 12:18 UTC |
Wittman LoriDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 11,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-049026 · tm2515150-6_4seq1.xml · derivative · entry 1 Wittman Lori · CIK 0001615562 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,581 Underlying: Common Stock · 11,518 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 14, 2026, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 14, 2025 Filed May 15, 2025 12:17 UTC |
Marston RonaldDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 11,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-049025 · tm2515150-5_4seq1.xml · derivative · entry 1 Marston Ronald · CIK 0001652392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,526 Underlying: Common Stock · 11,518 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 14, 2026, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 14, 2025 Filed May 15, 2025 12:14 UTC |
Crowley PaulaDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 11,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-049021 · tm2515150-3_4seq1.xml · derivative · entry 1 Crowley Paula · CIK 0001743595 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,581 Underlying: Common Stock · 11,518 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 14, 2026, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 14, 2025 Filed May 15, 2025 12:12 UTC |
Cole HenryDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 11,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-049017 · tm2515150-2_4seq1.xml · derivative · entry 1 Cole Henry · CIK 0001652393 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,526 Underlying: Common Stock · 11,518 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 14, 2026, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 20:49 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 23,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-018541 · tm257884-1_4seq1.xml · derivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 745,015 Underlying: Common Stock · 23,613 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 26, 2025, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2024 and February 26, 2025 and 50% of the LTIP Units will vest on February 26, 2026 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 01:51 UTC |
KIERNAN ROBERT JCFO and Treasurer
|
GrantLTIP Unit (Right to Buy) · Derivative | 13,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-018542 · tm257884-2_4seq1.xml · derivative · entry 2 KIERNAN ROBERT J · CIK 0001229248 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 428,374 Underlying: Common Stock · 13,493 shares Expires not disclosed F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 26, 2025, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2024 and February 26, 2025 and 50% of the LTIP Units will vest on February 26, 2026 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 01:51 UTC |
KIERNAN ROBERT JCFO and Treasurer
|
GrantLTIP Unit (Right to Buy) · Derivative | 46,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-018542 · tm257884-2_4seq1.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 414,881 Underlying: Common Stock · 46,069 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 26, 2028, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 01:55 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 7,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-018547 · tm257884-5_4seq1.xml · derivative · entry 2 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,573 Underlying: Common Stock · 7,826 shares Expires not disclosed F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 26, 2025, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2024 and February 26, 2025 and 50% of the LTIP Units will vest on February 26, 2026 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 01:55 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 24,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-018547 · tm257884-5_4seq1.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,747 Underlying: Common Stock · 24,570 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 26, 2028, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 01:53 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 8,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-018544 · tm257884-4_4seq1.xml · derivative · entry 2 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,620 Underlying: Common Stock · 8,770 shares Expires not disclosed F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 26, 2025, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2024 and February 26, 2025 and 50% of the LTIP Units will vest on February 26, 2026 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 01:53 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 25,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-018544 · tm257884-4_4seq1.xml · derivative · entry 1 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,850 Underlying: Common Stock · 25,799 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 26, 2028, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 01:52 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 12,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-018543 · tm257884-3_4seq1.xml · derivative · entry 2 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 457,283 Underlying: Common Stock · 12,650 shares Expires not disclosed F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 26, 2025, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2024 and February 26, 2025 and 50% of the LTIP Units will vest on February 26, 2026 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 01:52 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 46,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-018543 · tm257884-3_4seq1.xml · derivative · entry 1 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,633 Underlying: Common Stock · 46,069 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 26, 2028, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:36 UTC |
Cypher MatthewDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 9,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-062632 · tm2414766-2_4seq1.xml · derivative · entry 1 Cypher Matthew · CIK 0001670718 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,008 Underlying: Common Stock · 9,316 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 15, 2025, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:39 UTC |
Marston RonaldDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 9,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-062637 · tm2414766-5_4seq1.xml · derivative · entry 1 Marston Ronald · CIK 0001652392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,008 Underlying: Common Stock · 9,316 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 15, 2025, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:38 UTC |
Crowley PaulaDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 9,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-062636 · tm2414766-4_4seq1.xml · derivative · entry 1 Crowley Paula · CIK 0001743595 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,063 Underlying: Common Stock · 9,316 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 15, 2025, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:37 UTC |
Wittman LoriDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 9,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-062635 · tm2414766-3_4seq1.xml · derivative · entry 1 Wittman Lori · CIK 0001615562 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,063 Underlying: Common Stock · 9,316 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 15, 2025, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:34 UTC |
Cole HenryDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 9,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-062631 · tm2414766-1_4seq1.xml · derivative · entry 1 Cole Henry · CIK 0001652393 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,008 Underlying: Common Stock · 9,316 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 15, 2025, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 16:06 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 29,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027016 · tm247073-2_4seq1.xml · derivative · entry 2 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 721,402 Underlying: Common Stock · 29,384 shares Expires not disclosed F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 21, 2024, 50% of the LTIP Units became vested and nonforfeitable on February 21, 2024 as a result of meeting certain market-based performance criteria as of December 31, 2023, and 50% of the LTIP Units will vest on February 21, 2025 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 16:06 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 62,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027016 · tm247073-2_4seq1.xml · derivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 692,018 Underlying: Common Stock · 62,176 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 21, 2027, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:08 UTC |
KIERNAN ROBERT JCFO and Treasurer
|
GrantLTIP Unit (Right to Buy) · Derivative | 18,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027023 · tm247073-4_4seq1.xml · derivative · entry 2 KIERNAN ROBERT J · CIK 0001229248 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,812 Underlying: Common Stock · 18,549 shares Expires not disclosed F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 21, 2024, 50% of the LTIP Units became vested and nonforfeitable on February 21, 2024 as a result of meeting certain market-based performance criteria as of December 31, 2023, and 50% of the LTIP Units will vest on February 21, 2025 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:08 UTC |
KIERNAN ROBERT JCFO and Treasurer
|
GrantLTIP Unit (Right to Buy) · Derivative | 38,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027023 · tm247073-4_4seq1.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,263 Underlying: Common Stock · 38,860 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 21, 2027, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:09 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 15,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027025 · tm247073-5_4seq1.xml · derivative · entry 2 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398,564 Underlying: Common Stock · 15,742 shares Expires not disclosed F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 21, 2024, 50% of the LTIP Units became vested and nonforfeitable on February 21, 2024 as a result of meeting certain market-based performance criteria as of December 31, 2023, and 50% of the LTIP Units will vest on February 21, 2025 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:09 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 38,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027025 · tm247073-5_4seq1.xml · derivative · entry 1 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 382,822 Underlying: Common Stock · 38,860 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 21, 2027, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:06 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 11,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027020 · tm247073-3_4seq1.xml · derivative · entry 2 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,051 Underlying: Common Stock · 11,486 shares Expires not disclosed F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 21, 2024, 50% of the LTIP Units became vested and nonforfeitable on February 21, 2024 as a result of meeting certain market-based performance criteria as of December 31, 2023, and 50% of the LTIP Units will vest on February 21, 2025 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:06 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 21,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027020 · tm247073-3_4seq1.xml · derivative · entry 1 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,565 Underlying: Common Stock · 21,762 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 21, 2027, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:06 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 10,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027014 · tm247073-1_4seq1.xml · derivative · entry 2 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,177 Underlying: Common Stock · 10,249 shares Expires not disclosed F3 · security: Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 21, 2024, 50% of the LTIP Units became vested and nonforfeitable on February 21, 2024 as a result of meeting certain market-based performance criteria as of December 31, 2023, and 50% of the LTIP Units will vest on February 21, 2025 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:06 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 20,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027014 · tm247073-1_4seq1.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,928 Underlying: Common Stock · 20,725 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 21, 2027, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:56 UTC |
Cypher MatthewDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 8,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-058497 · tm2315309-3_4seq1.xml · derivative · entry 1 Cypher Matthew · CIK 0001670718 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,692 Underlying: Common Stock · 8,903 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 10, 2024, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:56 UTC |
Wittman LoriDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 8,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-058501 · tm2315309-5_4seq1.xml · derivative · entry 1 Wittman Lori · CIK 0001615562 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,747 Underlying: Common Stock · 8,903 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 10, 2024, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:55 UTC |
Crowley PaulaDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 8,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-058496 · tm2315309-2_4seq1.xml · derivative · entry 1 Crowley Paula · CIK 0001743595 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,747 Underlying: Common Stock · 8,903 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 10, 2024, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:56 UTC |
Marston RonaldDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 8,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-058498 · tm2315309-4_4seq1.xml · derivative · entry 1 Marston Ronald · CIK 0001652392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,692 Underlying: Common Stock · 8,903 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 10, 2024, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:54 UTC |
Cole HenryDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 8,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-058494 · tm2315309-1_4seq1.xml · derivative · entry 1 Cole Henry · CIK 0001652393 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,692 Underlying: Common Stock · 8,903 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 10, 2024, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 28, 2023 Filed Feb 28, 2023 19:18 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 13,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-026874 · tm238076-1_4seq1.xml · derivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 629,842 Underlying: Common Stock · 13,175 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2023, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2022 and February 28, 2023 and 50% of the LTIP Units will vest on February 28, 2024 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.